Characterization of the FKBP12-encoding genes in Aspergillus fumigatus

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Falloon, Katie ^a   Juvvadi, Praveen R ^b   Richards, Amber D ^b   Vargas Muñiz, José M ^b   Renshaw, Hilary ^b   Steinbach, William J ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CALCINEURIN; CASPOFUNGIN; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; FK 506 BINDING PROTEIN 12 1 EPIDERMAL GROWTH FACTOR FUSION PROTEIN; HYBRID PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG; CYCLOSPORIN; ECHINOCANDIN; LIPOPEPTIDE;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL NUCLEUS; CNAA GENE; CONTROLLED STUDY; CYTOPLASM; DRUG PROTEIN BINDING; FKBP12 GENE; FKBP12-1 GENE; FKBP12-2 GENE; FKBP12-3 GENE; FKBP12-4 GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS HYPHAE; GALLERIA MELLONELLA; GENE DELETION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOTH; PATHOGENICITY; PHYLOGENY;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CALCINEURIN; CYCLOSPORINE; ECHINOCANDINS; GENE DELETION; HUMANS; HYPHAE; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MOTHS; PHYLOGENY; TACROLIMUS; TACROLIMUS BINDING PROTEIN 1A;

EID: 84947571172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137869     Document Type: Article

References (73)

1. Latgé J-P. Aspergillus fumigatus and Aspergillosis. Clinical Microbiology Reviews. 1999; 12(2):310-50. PMID: PMC88920.
2. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010 Apr 15; 50(8):1091-100. PMID: 20218877. Epub 2010/03/12. eng.
3. Crabol Y, Lortholary O. Invasive Mold Infections in Solid Organ Transplant Recipients. Scientifica. 2014; 2014:17.
4. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2002 Apr 1; 34(7):909-17. PMID: 11880955. Epub 2002/03/07. eng.
5. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2002 Jan-Feb; 5(1):26-34. PMID: 11873380. Epub 2002/03/05. eng.
6. Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. The Journal of infection. 2012 Nov; 65(5):453-64. PMID: 22898389. Epub 2012/08/18. eng. doi: 10.1016/j.jinf.2012.08.003
7. Denning DW. Therapeutic outcome in invasive aspergillosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1996 Sep; 23(3):608-15. PMID: 8879787. Epub 1996/09/01. eng.
8. Brakhage AA. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Current drug targets. 2005 Dec; 6(8):875-86. PMID: 16375671. Epub 2005/12/27. eng.
9. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel antiinfective agent against invasive fungal infections. Nature reviews Microbiology. 2007 Jun; 5(6):418-30. PMID: 17505522. Epub 2007/05/17. eng.
10. Fox DS, Heitman J. Good fungi gone bad: the corruption of calcineurin. BioEssays: news and reviews in molecular, cellular and developmental biology. 2002 Oct; 24(10):894-903. PMID: 12325122. Epub 2002/09/27. eng.
11. Blankenship JR, Steinbach WJ, Perfect JR, Heitman J. Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. Current opinion in investigational drugs (London, England: 2000). 2003 Feb; 4(2):192-9. PMID: 12669381. Epub 2003/04/03. eng.
12. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Annals of internal medicine. 1987 Feb; 106(2):209-16. PMID: 3541723. Epub 1987/02/01. eng.
13. Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2003 Jan 1; 36(1):46-52. PMID: 12491201. Epub 2002/12/20. eng.
14. Steinbach WJ, Singh N, Miller JL, Benjamin DK, Schell WA, Heitman J, et al. In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients. Antimicrobial agents and chemotherapy. 2004; 48(12):4922-5. PMID: PMC529228.
15. Hemenway CS, Heitman J. Calcineurin. Structure, function, and inhibition. Cell Biochem Biophys. 1999; 30(1):115-51. PMID: 10099825. Epub 1999/04/01. eng.
16. Rusnak F, Mertz P. Calcineurin: Form and Function 2000 2000-01-10 00:00:00. 1483-521 p.
17. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23; 66(4):807-15. PMID: 1715244. Epub 1991/09/02. eng.
18. Arevalo-Rodriguez M, Wu X, Hanes SD, Heitman J. Prolyl isomerases in yeast. Frontiers in bioscience: a journal and virtual library. 2004 Sep 1; 9:2420-46. PMID: 15353296. Epub 2004/09/09. eng.
19. Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Current topics in medicinal chemistry. 2003; 3(12):1315-47. PMID: 12871165. Epub 2003/07/23. eng.
20. Pemberton TJ. Identification and comparative analysis of sixteen fungal peptidyl-prolyl cis/trans isomerase repertoires. BMC genomics. 2006; 7:244. PMID: 16995943. Pubmed Central PMCID: PMC1618848. Epub 2006/09/26. eng.
21. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, et al. The mechanism of action of cyclosporin A and FK506. Clinical immunology and immunopathology. 1996 Sep; 80(3 Pt 2):S40-5. PMID: 8811062. Epub 1996/09/01. eng.
22. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science (New York, NY). 1984 Nov 2; 226(4674):544-7. PMID: 6238408. Epub 1984/11/02. eng.
23. Jin L, Harrison SC. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. Proceedings of the National Academy of Sciences of the United States of America. 2002 Oct 15; 99(21):13522-6. PMID: 12357034. Pubmed Central PMCID: PMC129706. Epub 2002/10/03. eng.
24. Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 1995 8/11/; 82(3):507-22. PMID: 7543369
25. Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 1995 Dec 7; 378 (6557):641-4. PMID: 8524402. Epub 1995/12/07. eng.
26. Hemenway C, Heitman J. Calcineurin. Cell Biochem Biophys. 1999 1999/02/01; 30(1):115-51. English. PMID: 10099825
27. Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, et al. Crystal structure of calcineurin-cyclophilincyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proceedings of the National Academy of Sciences of the United States of America. 2002 Sep 17; 99(19):12037-42. PMID: 12218175. Pubmed Central PMCID: PMC129394. Epub 2002/09/10. eng.
28. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 1992 Jun 25; 357(6380):695-7. PMID: 1377362. Epub 1992/06/25. eng.
29. Feske S, Okamura H, Hogan PG, Rao A. Ca2+/calcineurin signalling in cells of the immune system. Biochemical and biophysical research communications. 2003 Nov 28; 311(4):1117-32. PMID: 14623298. Epub 2003/11/19. eng.
30. Juvvadi PR, Lamoth F, Steinbach WJ. Calcineurin-Mediated Regulation of Hyphal Growth, Septation, and Virulence in Aspergillus fumigatus. Mycopathologia. 2014 Aug 15. PMID: 25118871. Epub 2014/08/15. Eng.
31. Steinbach WJ, Cramer RA Jr, Perfect BZ, Asfaw YG, Sauer TC, Najvar LK, et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryotic cell. 2006 Jul; 5(7):1091-103. PMID: 16835453. Pubmed Central PMCID: PMC1489296. Epub 2006/07/13. eng.
32. Juvvadi PR, Fortwendel JR, Rogg LE, Burns KA, Randell SH, Steinbach WJ. Localization and activity of the calcineurin catalytic and regulatory subunit complex at the septum is essential for hyphal elongation and proper septation in Aspergillus fumigatus. Molecular microbiology. 2011 Dec; 82(5):1235-59. PMID: 22066998. Pubmed Central PMCID: PMC3225650. Epub 2011/11/10. eng. doi: 10.1111/j.1365-2958.2011.07886.x
33. Juvvadi PR, Fortwendel JR, Pinchai N, Perfect BZ, Heitman J, Steinbach WJ. Calcineurin Localizes to the Hyphal Septum in Aspergillus fumigatus: Implications for Septum Formation and Conidiophore Development. Eukaryotic cell. 2008; 7(9):1606-10. PMID: PMC2547068. doi: 10.1128/EC.00200-08
34. Juvvadi PR, Gehrke C, Fortwendel JR, Lamoth F, Soderblom EJ, Cook EC, et al. Phosphorylation of Calcineurin at a Novel Serine-Proline Rich Region Orchestrates Hyphal Growth and Virulence in Aspergillus fumigatus. PLoS pathogens. 2013; 9(8):e1003564. PMID: PMC3749960. doi: 10.1371/journal. ppat.1003564
35. Kraus PR, Heitman J. Coping with stress: calmodulin and calcineurin in model and pathogenic fungi. Biochemical and biophysical research communications. 2003 Nov 28; 311(4):1151-7. PMID: 14623301. Epub 2003/11/19. eng.
36. Onyewu C, Blankenship JR, Del Poeta M, Heitman J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrobial agents and chemotherapy. 2003 Mar; 47(3):956-64. PMID: 12604527. Pubmed Central PMCID: PMC149324. Epub 2003/02/27. eng.
37. Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Annals of internal medicine. 2015 Jan 20; 162 (2):81-9. PMID: 25599346. Epub 2015/01/20. eng. doi: 10.7326/M13-2508
38. MacMillan D. FK506 binding proteins: cellular regulators of intracellular Ca2+ signalling. European journal of pharmacology. 2013 Jan 30; 700(1-3):181-93. PMID: 23305836. Epub 2013/01/12. eng. doi: 10.1016/j.ejphar.2012.12.029
39. MacMillan D, McCarron JG. Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR. British journal of pharmacology. 2009 Oct; 158(4):1112-20. PMID: 19785652. Pubmed Central PMCID: PMC2785532. Epub 2009/09/30. eng. doi: 10.1111/j.1476-5381.2009.00369.x
40. MacMillan D, Currie S, McCarron JG. FK506-binding protein (FKBP12) regulates ryanodine receptorevoked Ca2+ release in colonic but not aortic smooth muscle. Cell calcium. 2008 Jun; 43(6):539-49. PMID: 17950843. Epub 2007/10/24. eng.
41. MacMillan D, Currie S, Bradley KN, Muir TC, McCarron JG. In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin. Journal of cell science. 2005 Dec 1; 118(Pt 23):5443-51. PMID: 16278292. Epub 2005/11/10. eng.
42. Huse M, Chen YG, Massague J, Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 1999 Feb 5; 96(3):425-36. PMID: 10025408. Epub 1999/02/20. eng.
43. Yao D, Dore JJ Jr, Leof EB. FKBP12 is a negative regulator of transforming growth factor-beta receptor internalization. The Journal of biological chemistry. 2000 Apr 28; 275(17):13149-54. PMID: 10777621. Epub 2000/04/25. eng.
44. Girgenrath T, Mahalingam M, Svensson B, Nitu FR, Cornea RL, Fessenden JD. N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins. The Journal of biological chemistry. 2013 May 31; 288(22):16073-84. PMID: 23585572. Pubmed Central PMCID: PMC3668763. Epub 2013/04/16. eng. doi: 10.1074/jbc.M113.463299
45. Dolinski K, Muir S, Cardenas M, Heitman J. All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America. 1997 Nov 25; 94(24):13093-8. PMID: 9371805. Pubmed Central PMCID: PMC24268. Epub 1997/12/16. eng.
46. Pinto D, Duarte M, Soares S, Tropschug M, Videira A. Identification of all FK506-binding proteins from Neurospora crassa. Fungal genetics and biology: FG & B. 2008 Dec; 45(12):1600-7. PMID: 18948221. Epub 2008/10/25. eng.
47. Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (New York, NY). 1991 Aug 23; 253(5022):905-9. PMID: 1715094. Epub 1991/08/23. eng.
48. Hemenway C, Heitman J. Proline isomerases in microorganisms and small eukaryotes. Annals of the New York Academy of Sciences. 1993 Nov 30; 696:38-46. PMID: 8109845. Epub 1993/11/30. eng.
49. Teichert S, Wottawa M, Schonig B, Tudzynski B. Role of the Fusarium fujikuroi TOR kinase in nitrogen regulation and secondary metabolism. Eukaryotic cell. 2006 Oct; 5(10):1807-19. PMID: 17031002. Pubmed Central PMCID: PMC1595341. Epub 2006/10/13. eng.
50. Gioti A, Simon A, Le Pecheur P, Giraud C, Pradier JM, Viaud M, et al. Expression profiling of Botrytis cinerea genes identifies three patterns of up-regulation in planta and an FKBP12 protein affecting pathogenicity. J Mol Biol. 2006 Apr 28; 358(2):372-86. PMID: 16497329. Epub 2006/02/25. eng.
51. Meléndez HG, Billon-Grand G, Fèvre M, Mey G. Role of the Botrytis cinerea FKBP12 ortholog in pathogenic development and in sulfur regulation. Fungal Genetics and Biology. 2009 4//; 46(4):308-20. doi: 10.1016/j.fgb.2008.11.011 PMID: 19116175
52. Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, et al. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrobial agents and chemotherapy. 2001 Nov; 45 (11):3162-70. PMID: 11600372. Pubmed Central PMCID: PMC90798. Epub 2001/10/16. eng.
53. Cruz MC, Cavallo LM, Gorlach JM, Cox G, Perfect JR, Cardenas ME, et al. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Molecular and cellular biology. 1999 Jun; 19(6):4101-12. PMID: 10330150. Pubmed Central PMCID: PMC104369. Epub 1999/05/18. eng.
54. Calo S, Shertz-Wall C, Lee SC, Bastidas RJ, Nicolas FE, Granek JA, et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. Nature. 2014 Jul 27. PMID: 25079329. Epub 2014/08/01. Eng.
55. Bastidas RJ, Shertz CA, Lee SC, Heitman J, Cardenas ME. Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. Eukaryotic cell. 2012 Mar; 11(3):270-81. PMID: 22210828. Pubmed Central PMCID: PMC3294450. Epub 2012/01/03. eng. doi: 10.1128/EC.05284-11
56. d'Enfert C. Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5′-decarboxylase gene, pyrG, as a unique transformation marker. Current genetics. 1996 Jun; 30(1):76-82. PMID: 8662213. Epub 1996/06/01. eng.
57. da Silva Ferreira ME, Kress MR, Savoldi M, Goldman MH, Hartl A, Heinekamp T, et al. The akuB (KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryotic cell. 2006 Jan; 5(1):207-11. PMID: 16400184. Pubmed Central PMCID: PMC1360264. Epub 2006/01/10. eng.
58. Shimizu K, Keller NP. Genetic involvement of a cAMP-dependent protein kinase in a G protein signaling pathway regulating morphological and chemical transitions in Aspergillus nidulans. Genetics. 2001 Feb; 157(2):591-600. PMID: 11156981. Pubmed Central PMCID: PMC1461531. Epub 2001/02/07. eng.
59. Fortwendel JR, Juvvadi PR, Pinchai N, Perfect BZ, Alspaugh JA, Perfect JR, et al. Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrobial agents and chemotherapy. 2009 Feb; 53(2):476-82. PMID: 19015336. Pubmed Central PMCID: PMC2630655. Epub 2008/11/19. eng. doi: 10.1128/AAC.01154-08
60. Reeves EP, Messina CG, Doyle S, Kavanagh K. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia. 2004 Jul; 158(1):73-9. PMID: 15487324. Epub 2004/10/19. eng.
61. Kay JE. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. The Biochemical journal. 1996 Mar 1; 314 (Pt 2):361-85. PMID: 8670043. Pubmed Central PMCID: PMC1217058. Epub 1996/03/01. eng.
62. Stevens DA, Espiritu M, Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrobial agents and chemotherapy. 2004 Sep; 48(9):3407-11. PMID: 15328104. Pubmed Central PMCID: PMC514730. Epub 2004/08/26. eng.
63. Wiederhold NP. Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Current Opinion in Infectious Diseases. 2007; 20(6):574-8. PMID: 00001432-200712000-00004.
64. Lewis RE, Albert ND, Kontoyiannis DP. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. The Journal of antimicrobial chemotherapy. 2008 May; 61(5):1140-4. PMID: 18305201. Epub 2008/02/29. eng. doi: 10.1093/jac/dkn069
65. Helbig JH, Konig B, Knospe H, Bubert B, Yu C, Luck CP, et al. The PPIase active site of Legionella pneumophila Mip protein is involved in the infection of eukaryotic host cells. Biological chemistry. 2003 Jan; 384(1):125-37. PMID: 12674506. Epub 2003/04/04. eng.
66. Pereira PJ, Vega MC, Gonzalez-Rey E, Fernandez-Carazo R, Macedo-Ribeiro S, Gomis-Ruth FX, et al. Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed alpha-helix. EMBO reports. 2002 Jan; 3(1):88-94. PMID: 11751578. Pubmed Central PMCID: PMC1083928. Epub 2001/12/26. eng.
67. Niu XW, Zheng ZY, Feng YG, Guo WZ, Wang XY. The Fusarium Graminearum virulence factor FGL targets an FKBP12 immunophilin of wheat. Gene. 2013 Aug 1; 525(1):77-83. PMID: 23648486. Epub 2013/05/08. eng. doi: 10.1016/j.gene.2013.04.052
68. Alarcon CM, Heitman J. FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. Molecular and cellular biology. 1997 Oct; 17(10):5968-75. PMID: 9315655. Pubmed Central PMCID: PMC232445. Epub 1997/10/07. eng.
69. Steinbach WJ, Juvvadi PR, Fortwendel JR, Rogg LE. Newer combination antifungal therapies for invasive aspergillosis. Medical mycology. 2011 Apr; 49 Suppl 1:S77-81. PMID: 20608784. Epub 2010/07/09. eng. doi: 10.3109/13693786.2010.499374
70. Wenzel R, Del Favero A, Kibbler C, Rogers T, Rotstein C, Mauskopf J, et al. Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. The Journal of antimicrobial chemotherapy. 2005 Mar; 55(3):352-61. PMID: 15728146. Epub 2005/02/25. eng.
71. Lee EH, Rho SH, Kwon SJ, Eom SH, Allen PD, Kim do H. N-terminal region of FKBP12 is essential for binding to the skeletal ryanodine receptor. The Journal of biological chemistry. 2004 Jun 18; 279 (25):26481-8. PMID: 15033987. Epub 2004/03/23. eng.
72. Fuchs BB, O'Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence. 2010 Nov-Dec; 1(6):475-82. PMID: 21178491. Epub 2010/12/24. eng.
73. Fallon JP, Troy N, Kavanagh K. Pre-exposure of Galleria mellonella larvae to different doses of Aspergillus fumigatus conidia causes differential activation of cellular and humoral immune responses. Virulence. 2011 Sep-Oct; 2(5):413-21. PMID: 21921688. Epub 2011/09/17. eng. doi: 10.4161/viru.2.5. 17811